Enovis (ENOV) Stock Forecast: StockMap's 2-Week Call
ENOV stock forecast: StockMap's model makes no two-week call on Enovis after the Nov 19 close: its evidence is split, 6 reasons for and 9 against. Right in 4 of 6 two-week windows on ENOV since Aug 21; by chance, a call on the same dates was right 59% of the time.
Enovis last closed at $26.23, -3.21% on the session.
Against the IVW growth benchmark the position is -0.88% over the forecast window.
Enovis' market cap is $1.51B as of November 19, 2026.
No call today: the model sees no clear direction · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -13 (too close to call).
Where ENOV sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 6 bullish and 9 bearish.
Agreement across those insights is 60%.
49 daily calls for ENOV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Enovis in the 22nd percentile on return on equity, where 100 is best.
Enovis is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Enovis as the 50th largest of the 141 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 69 Neutral, 55 Moderate Underperform, 14 Strong Underperform and 3 Moderate Outperform.
On that composite Enovis ranks 60th of 141 in the group, against a group median of -0.18.